To systematically investigate the underlying molecular mechanism mediating CACNA2D3-induced ESCC cisplatin sensitivity, we compared the expression profiles of KYSE30 cells with and without CACNA2D3 overexpression after cisplatin treatment using RNA-seq. This evidence concerns the gene CACNA2D3 and esophageal squamous cell carcinoma.